Codergocrine Mesilate

A mixture of dihydroergocornine mesilate (C31H41N5O5,CH4O3S = 659.8), dihydroergocristine mesilate, ?-dihydroergocryptine mesilate, and ?-dihydroergocryptine mesilate (epicriptine mesilate). It contains 30 to 35% of dihydroergocornine, 30 to 35% of dihydroergocristine, 20 to 25% of ?-dihydroergocryptine, and 10 to 13% of ?-dihydroergocryptine.


Effects on the gastrointestinal tract. A 67-year-old woman experienced severe vomiting after rivastigmine, in an oral dose of 4.5 mg, was mistakenly reintroduced without the recommended titration phase; the vomiting was so severe that the patient also suffered a rupture of the oesophagus that needed corrective surgery.

Memantine Hydrochloride

Common adverse effects with memantine include constipation, dizziness, headache, hypertension, and somnolence. Less common reactions such as anxiety, hallucinations, confusion, fatigue, abnormal gait, hypertonia, vomiting, fungal infections, cystitis, thromboembolism, and increased libido have also occurred. Isolated cases of psychotic reactions and pancreatitis have been reported.